Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Ascletis Pharma Completes Phase Two Enrollment for Oral Diabetes Treatment
Ascletis Pharma recently completed enrollment for a phase two clinical study. The clinical trial evaluates an investigational oral therapy for the treatment of type 2 diabetes. This research involves one hundred randomized participants across multiple testing facilities. Furthermore, the company…